Key result
Continuing mechanical thrombectomy after achieving early mTICI 2b reperfusion did not significantly improve functional outcome at 90 days (OR 0.75) compared to stopping, but was associated with a higher risk of symptomatic intracranial hemorrhage.
Why the study?
It remains unclear if continuing mechanical thrombectomy after early mTICI 2b reperfusion improves functional outcome or increases risk of intracranial hemorrhage.
Cohort (n=100)
No
Odds Ratio: 0.75 (95% CI 0.19–2.87)
Absolute Event Rate: 40.1% vs 35.6%
p-value: p=0.667
Background Successful reperfusion (mTICI 2c/3) and low number of passes are key determinants for good clinical outcome in acute large vessel occlusion. While final mTICI 2c/3 reperfusion is superior to partial reperfusion (mTICI 2b) it remains unclear if this is also true for the subgroup of patients with early mTICI 2b (achieved in ≤2 retrieval attempts) reperfusion who are secondarily improved to mTICI 2c/3. This study was designed to examine if early mTICI2b should be continued or stopped during mechanical thrombectomy (MT). Methods Nine hundred and thirteen ischemic stroke patients who received MT were retrospectively analyzed. Angiography runs following each recanalization attempt were scored for mTICI. The patients with early mTICI 2b reperfusions were dichotomized in “TICI2b-stopped” (MT withdrawal after mTICI 2b was achieved with first or second retrieval) and “TICI2b-continued” (MT was continued after mTICI 2b was achieved with first or second retrieval). Functional outcome was obtained after 90 days using the modified Rankin scale (mRS90). Results Of 362 Patients with a M1-occlusion, 100 patients fulfilled the inclusion criteria with an early mTICI 2b. 78/100 patients were included in the “TICI2b-stopped” group and 22/100 patients were in the “TICI2b-continued” group. Of these 22 patients, none had a final mTICI score lower than 2b and 11 patients had a final mTICI score of 2c/3. Regarding good functional outcome at mRS90, “TICI2b-continued” showed by trend a slight advantage of 40.1 vs. 35.6% in “TICI2b-stopped” but in multivariate logistic regression analysis adjusted for confounders, no significant difference was found between the two groups (OR 0.75, 95% CI 0.19–2.87, p = 0.67). Symptomatic intracranial hemorrhage was significantly higher in “TICI2b-continued” compared to “TICI2b-stopped” (31.8 vs. 10.3%, p = 0.031). Conclusion Successfully improving an early mTICI 2b to mTICI 2c/3 reperfusion is possible in a substantial number of patients and might improve functional outcome. However, an increase in symptomatic intracranial hemorrhage (SICH) due to further retrieval attempts may diminish the potential functional benefit to continue early mTICI 2b. To support this finding, further investigation with more power is needed to account for the low number of events regarding SICH.
No takes yet. Share an insight, caveat, or question.
Steffen et al. (2022) conducted a cohort in Acute ischemic stroke with large vessel occlusion (n=100). Continuing mechanical thrombectomy vs. Stopping mechanical thrombectomy was evaluated on Good functional outcome (mRS ≤ 2) at 90 days (OR 0.75, 95% CI 0.19-2.87, p=0.667). Continuing mechanical thrombectomy after achieving early mTICI 2b reperfusion did not significantly improve functional outcome at 90 days (OR 0.75) compared to stopping, but was associated with a higher risk of symptomatic intracranial hemorrhage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: